N
Neil M. Bressler
Researcher at Johns Hopkins University
Publications - 106
Citations - 10837
Neil M. Bressler is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Macular degeneration & Visual acuity. The author has an hindex of 48, co-authored 106 publications receiving 9813 citations. Previous affiliations of Neil M. Bressler include Chiang Mai University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
An international classification and grading system for age-related maculopathy and age-related macular degeneration
Alan C. Bird,Neil M. Bressler,Susan B. Bressler,I H Chisholm,Gabriel Coscas,M.D. Davis,P.T.V.M. de Jong,Caroline C W Klaver,Barbara E.K. Klein,Ronald Klein,Philip B. Mitchell,J.P. Sarks,S.H. Sarks,Gisèle Soubrane,Hugh R. Taylor,Johannes R. Vingerling +15 more
TL;DR: A common detection and classification system is needed for epidemiologic studies of age-related maculopathy (ARM) and such a grading scheme for ARM is described in this paper.
Journal ArticleDOI
Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
Daniel Shu Wei Ting,Daniel Shu Wei Ting,Carol Y. Cheung,Carol Y. Cheung,Gilbert Lim,Gavin Tan,Gavin Tan,Nguyen Duc Quang,Alfred Tau Liang Gan,Haslina Hamzah,Renata Garcia-Franco,Ian Yew San Yeo,Ian Yew San Yeo,Shu Yen Lee,Shu Yen Lee,Edmund Yick Mun Wong,Edmund Yick Mun Wong,Charumathi Sabanayagam,Charumathi Sabanayagam,Mani Baskaran,Mani Baskaran,Farah Nur Ilyana Mohd Ibrahim,Ngiap Chuan Tan,Ngiap Chuan Tan,Eric A. Finkelstein,Ecosse L. Lamoureux,Ecosse L. Lamoureux,Ian Y. H. Wong,Neil M. Bressler,Sobha Sivaprasad,Rohit Varma,Jost B. Jonas,Mingguang He,Ching-Yu Cheng,Ching-Yu Cheng,Gemmy Cheung,Gemmy Cheung,Tin Aung,Tin Aung,Wynne Hsu,Mong Li Lee,Tien Yin Wong,Tien Yin Wong +42 more
TL;DR: In this evaluation of retinal images from multiethnic cohorts of patients with diabetes, the DLS had high sensitivity and specificity for identifying diabetic retinopathy and related eye diseases.
Journal ArticleDOI
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1
Jennifer J. Arnold,D. Kilmartin,Jay A. Olson,S. Neville,K. Robinson,Angela R. Laird,C. Richmond,A. Farrow,S. McKay,David A. Saperstein,Thomas M. Aaberg,Joshua Johnson,R. Waldron,D. Loupe,J. Gillman,B. Myles,Andrew P. Schachat,Neil M. Bressler,Susan B. Bressler,P. Nesbitt,T. Porter,P. Hawse,Mary Elizabeth Hartnett,A. Eager,J. Belt,D. Cain,D. Emmert,T. George,M. Herring,J. McDonald,Jordi Monés,B. Corcostegui,M. Gilbert,N. Duran,M. Sisquella,A. Nolla,A. Margalef,Joan W. Miller,Evangelos S. Gragoudas,Anne Marie Lane,N. Emmanuel,A. Holbrook,Conor L. Evans,U. S. Lord,D. K. Walsh,C. D. Callahan,J. L. DuBois,Hilel Lewis,Peter K. Kaiser,L. J. Holody,E. Lesak,Susan Lichterman,H. Siegel,A. Fattori,G. Ambrose,T. Fecko,D. Ross,Shanna L. Burke,Lawrence J. Singerman,Hernando Zegarra,Michael A. Novak,M. Bartel,K. Tilocco-DuBois,M. Iic,S. Schura,S. J. Mayes,V. Tanner,P. Rowe,S. Smith-Brewer,D. Kukula,Gregg Greanoff,Geraldine Daley,John DuBois,D. Lehnhardt,Gary E. Fish,Bradley F. Jost,Rajiv Anand,David Callanan,Sally Arceneaux,J. Arnwine,P. Ellenich,J. King,Hank Aguado,R. Rollins,B. Jurklies,D. Pauleikhoff,A. Hintzmann,Michael Fischer,C. Sowa,E. Behne,Constantin J. Pournaras,Guy Donati,A. D. Kapetanios,K. Cavaliere,S. Guney-Wagner,N. Gerber,M. Sickenberg,V. Sickenberg,A. Gans,B. Hosner,A. Sbressa,C. Kozma,M. Curchod,S. A. Cancelli,Simon P. Harding,Y. C. Yang,M. C. Briggs,S. Briggs,V. Tompkin,R. Jackson,S. Pearson,S. Natha,J. Sharp,J. I. Lim,Christina J. Flaxel,M. Padilla,Leonard A. Levin,F. Walonker,L. Cisneros,T. Nichols,Ursula Schmidt-Erfurth,Irene Barbazetto,H. Laqua,R. Kupfer,R. Bulow,B. Glisovic,T. Bredfeldt,H. Elsner,V. Wintzer,D. Bahlmann,Stephan Michels,Mark S. Blumenkranz,Hunter L. Little,Robert L. Jack,L. M. Espiritu,L. Unyi,J. Regan,L. Lamborn,C. Silvestri,Robert H. Rosa,Philip J. Rosenfeld,Mary Lou Lewis,B. Rodriguez,A. Torres,N. Munoz,T. Contreras,M. Galvez,D. Hess,T. Cubillas,I. Rams,Jason S. Slakter,John A. Sorenson,P. A. Bruschi,Katherine Burke,E. Schnipper,Leandro Maranan,M. Scolaro,M. Riff,E. Agresta,I. Johansson,I. Dedorsson,S. Stenkula,C. Hvarfner,T. Carlsson,A. M. Liljedahl,S. Fallstrom,E. Jacobsson,Gisèle Soubrane,D. Kuhn,H. Oubraham,A. Benelhani,A. Kunsch,B. Delhoste,G. Ziverec,M. Lasnier,L. A. Lobes,Karl R. Olsen,B. J. Bahr,N. T. Worstell,L. A. Wilcox,L. A. Wellman,G. Vagstad,David M. Steinberg,Alan Campbell,Richard F. Dreyer,B. Williamson,Marvin Johnson,H. Crider,Raymond R. Margherio,George A. Williams,M. Zajechowski,C. Stanley,M. Kulak,P. Streasick,L. Szdlowski,R. Falk,S. Shoichet,G. Regan,P. Manatrey,K. Cumming,F. Koenig,Mustapha Benchaboune,K. Mezmate,S. Fontanay,Travis A. Meredith,J. Binning,J. Gualdoni,L. Boyd,E. Ort,B. Barts,Robert C. Allen,J. Dahl,T. Holle,P. T. Harvey,L. Kaus,D. Leuschner,S. Bolychuk,I. Hewitt,Ugo Menchini,Francesco Bandello,Gianni Virgili,Paolo Lanzetta,M. Ambesi,Angelo Pirracchio,Massimiliano Tedeschi,Michael J. Potter,B. Sahota,Lars Hall,Michael Stur,J. Lukas,Michael Tittl,S. Docker,K. Vogl,D. J. Pieramici,Kelly S Manos,R. Cooper,R. L. Denbow,E. R. Lowery,Dawn Phillips,S. K. Thibeault,Y. Tian,M. Harnett,N. Black,P. Escartin,D. Hartley,P. Haworth,T. Hecker,D. Hiscock,F. Jamali,N. Maradan,J. North,B. Norton,T. Stapleton-Hayes,Roy Taylor,G. Huber,J. Y. Deslandes,Mario Fsadni,I. Hess,H. de Pommerol,A. Bobillier,Reaves A,S. Banasik,John M Koester,Todd Gray,K. Truett,J. Baker,L. McAlister,R. Birch,A. Strong,M. Azab,N. Buskard,U. Manjuris,Y. Hao,M. Mason,U. McCurry,Reginald Birngruber,P. Harvey,J. M. Koester,C. Ma,Susan A. Murphy,S. Soubrane,Strong Ha,H. van den Berg,R. W. Beck,Alan C. Bird,Gabriel Coscas,A. Deutman,Lee M. Jampol,Ronald Klein,Maureen G. Maguire,P. Rosenfeld,R. P. Margherio,P. Staflin +292 more
TL;DR: Because photodynamic therapy with verteporfin can safely increase the chance of stabilizing or improving vision in patients with subfoveal CNV from pathologic myopia compared with a placebo, it is recommended ophthalmologists consider vertEPorfin therapy for treatment of such patients.
Journal ArticleDOI
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.
Neil M. Bressler,Susan B. Bressler,Nathan Congdon,Ferris Fl rd,David S. Friedman,Ronald Klein,Anne S. Lindblad,Roy C. Milton,Johanna M. Seddon +8 more
TL;DR: If people at high risk for advanced AMD received supplements such as those suggested by AREDS results, the potential impact on public health in the United States would be considerable during the next 5 years.
Journal ArticleDOI
Frequency of Adverse Systemic Reactions after Fluorescein Angiography: Results of a Prospective Study
Kris A. Kwiterovich,Maureen G. Maguire,Robert P. Murphy,Andrew P. Schachat,Neil M. Bressler,Susan B. Bressler,Stuart L. Fine +6 more
TL;DR: In a prospective study of 2789 angiographic procedures in 2025 patients, the authors found that the percentage of adverse reactions depended strongly on the patient's angiography history as discussed by the authors.